Vassilakopoulos, T. P., Panitsas, F., Mellios, Z., Apostolidis, J., Michael, M., Gurion, R., Ferhanoglu, B., Hatzimichael, E., Karakatsanis, S., Dimou, M., Kalpadakis, C., Katodritou, E., Leonidopoulou, T., Kotsianidis, I., Giatra, H., Kanellias, N., Sayyed, A., Tadmor, T., Akay, O. M., Angelopoulou, M. K., Horowitz, N., Bakiri, M., Pangalis, G. A., Panayiotidis, P., & Papageorgiou, S. G. (2023). incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era. Hematological oncology, 41(1), 97–107. http://access.bl.uk/ark:/81055/vdc_100176522603.0x000045